5 Healthcare Stocks to Watch in Light of Biden’s ‘60 Minutes’ Interview

2. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 45

Year-to-Date Performance: -48.03%

Moderna, Inc. (NASDAQ:MRNA) is a healthcare company working to develop messenger RNA therapeutics and vaccines. The company is based in Cambridge, Massachusetts.

Jasper Hellweg at Argus lowered his price target on Moderna, Inc. (NASDAQ:MRNA) shares on September 14 from $180 to $150. The analyst still holds a Buy rating on the stock.

On September 29, Moderna, Inc. (NASDAQ:MRNA) hit its 52-week low. The stock fell 9% a day after Biden’s interview. The company’s projected EPS growth is also negative, standing at -35.4%.

There were 45 funds long Moderna, Inc. (NASDAQ:MRNA) in the second quarter, and 41 funds long the stock in the previous quarter. Their total stake values were $2.6 billion and $3.8 billion, respectively.